| # | Country | Total Patents | |
|---|---|---|---|
| #1 | EPO (European Patent Office) | 4 | |
| #2 | United States | 3 | |
| #3 | Australia | 2 | |
| #4 | Canada | 2 | |
| #5 | WIPO (World Intellectual Property Organization) | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology | |
| #3 | Agriculture |
| # | Technology | |
|---|---|---|
| #1 | Peptides | |
| #2 | Therapeutic chemical compounds | |
| #3 | Medical preparations | |
| #4 | Microorganisms | |
| #5 | Animal care |
| # | Name | Total Patents |
|---|---|---|
| #1 | Cuvillier Armelle | 12 |
| #2 | Champier Gaël | 5 |
| #3 | Moog Christiane | 4 |
| #4 | El Habib Raphaelle Claude | 2 |
| #5 | Sodoyer Régis | 2 |
| #6 | Laffleur Brice | 2 |
| #7 | Cogne Michel | 2 |
| #8 | El Habib Raphaëlle Claude | 2 |
| #9 | Bosselut Marie | 2 |
| #10 | Sodoyer Regis | 2 |
| Publication | Filing date | Title |
|---|---|---|
| EP3398967A1 | Antibodies against carcinoembryonic antigen for cancer therapy and diagnosis | |
| AU2015215643A1 | A new non-HIV vaccine antigen from the vaginal microbiota capable of inducing a mucosal neutralizing protective antibody response against HIV infection | |
| US2016157468A1 | Transgenic non-human mammal for producing chimeric human immunoglobulin E antibodies |